No earnings within 2 weeks of this transaction.
| Insider | Schneider Eugene |
|---|---|
| Title | EVP, Chf Clinical Develop Ofcr |
| Transaction Date | Mar 19, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 23, 2026 |
| Shares Sold | 5,812 |
| Price per Share | $70.97 |
| Total Value | $412,486.36 |
| Shares Owned After | 63,890 |
| Derivative | No |
| Accession Number | 0000874015-26-000152 |
| Document | View SEC Filing |